{"id":15052,"date":"2026-08-12T01:43:21","date_gmt":"2026-08-12T08:43:21","guid":{"rendered":"https:\/\/cellpeptides.com\/?post_type=product&#038;p=15052"},"modified":"2026-08-18T03:25:44","modified_gmt":"2026-08-18T10:25:44","slug":"buy-igf-1-lr3","status":"publish","type":"product","link":"https:\/\/cellpeptides.com\/lt\/product\/buy-igf-1-lr3\/","title":{"rendered":"IGF-1 LR3"},"content":{"rendered":"<h2><span style=\"font-weight: 400;\">Kas yra IGF-1 LR3?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Visas IGF-1 LR3 pavadinimas yra ilgasis arginino 3 \u012f insulin\u0105 pana\u0161us augimo faktorius 1. Tai laboratorijoje modifikuotas sintetinis hormonas, pasi\u017eymintis specifin\u0117mis savyb\u0117mis, kurios gali b\u016bti naudingesn\u0117 u\u017e nat\u016bral\u0173 IGF-1. Mokslin\u0117se diskusijose da\u017enai apra\u0161omas jo vartojimas po oda (subkutani\u0161kai) tyrim\u0173 protokoluose, kuriuos l\u0119di bent jau gydymo trukmei prilygstanti pertrauka, siekiant i\u0161vengti tolerancijos.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Kaip veikia IGF-1 LR3?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Tyrim\u0173 modeliuose, IGF-1 LR3 pasijungus prie IGF-1 receptori\u0173, aktyvuojama \u012fvyki\u0173 seka viename i\u0161 dviej\u0173 signalini\u0173 keli\u0173. Baltym\u0173 sintez\u0119 reguliuoja PI3 kelias, kuriame IGF-1 LR3 tiriamas d\u0117l kaskados, galin\u010dios paskatinti didesn\u012f raumen\u0173 baltym\u0173 susidarym\u0105 po treniruot\u0117s, stimuliavimo. Tai atliekama aktyvuojant griau\u010di\u0173 raumen\u0173 palydovines l\u0105steles, kurios diferencijuojasi \u012f mioblastus, kad suformuot\u0173 naujas raumen\u0173 skaidulas, auginan\u010dias ir atstatan\u010dias raumenis.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Kadangi IGF-1 LR3 yra \u012f insulin\u0105 pana\u0161us augimo faktorius, jis taip pat yra tiriamas d\u0117l \u012f insulin\u0105 pana\u0161aus aktyvumo organizme. Jis gali tur\u0117ti \u012ftakos raumen\u0173 maistini\u0173 med\u017eiag\u0173 pasisavinimui, leisdamas l\u0105stel\u0117ms \u012fsisavinti daugiau gliukoz\u0117s ir aminor\u016bg\u0161\u010di\u0173.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">IGF-1 LR3 panaudojimo atvejai<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">IGF-1 LR3 yra aptariamas mokslini\u0173 tyrim\u0173 kontekste d\u0117l jo poveikio darbingumui, sen\u0117jimui ir k\u016bno sud\u0117ties procesams. Tai apima:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Raumen\u0173 regeneracija \u2013 tyrim\u0173 modeliuose tiriama peptide esanti baltym\u0173 sintez\u0117, kuri gali lemti didesn\u012f raumen\u0173 augim\u0105 po treniruot\u0117s.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Maistini\u0173 med\u017eiag\u0173 pasisavinimas \u2013 tai dar vienas b\u016bdas, kuriuo tyr\u0117jai nagrin\u0117ja IGF-1 LR3, vertindami efektyvum\u0105, kuriuo maistin\u0117s med\u017eiagos pasiekia raumen\u0173 l\u0105steles.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Rebal\u0173 ma\u017einimas \u2014 IGF-1 LR3 tiriamas d\u0117l jo poveikio metabolizmui. Kadangi jis taip pat tiriamas d\u0117l raumen\u0173 vystymosi, tyr\u0117jai vertina, ar jis gali paveikti riebal\u0173 apykait\u0105 ir kartu i\u0161laikyti lies\u0105 raumen\u0173 mas\u0119.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Sportin\u0117 regeneracija \u2013 \u0161is peptidas yra tiriamas d\u0117l audini\u0173 gijimo ir atsistatymo, \u012fskaitant raumenis, sausgysles ir rai\u0161\u010dius. \u0160iuose tyrimuose vertinamas diskomfortas, u\u017edegimas, atsistatymo laikas ir traum\u0173 modeliai.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">L\u0105steli\u0173 gijimas \u2013 IGF-1 LR3 tiriamas sen\u0117jimo biologijos ir mink\u0161t\u0173j\u0173 audini\u0173 pa\u017eeidim\u0173 modeliuose, o ne kaip patvirtintas estetinis ar atsistatymo sprendimas.<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">IGF-1 LR3 palyginti su \u012fprastu IGF-1<\/span><\/h2>\n<p><a href=\"https:\/\/medlineplus.gov\/lab-tests\/igf-1-insulin-like-growth-factor-1-test\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">IGF-1<\/span><\/a><span style=\"font-weight: 400;\"> yra hormonas, kur\u012f gamina kepenys ir kuris i\u0161siskiria \u012f kraujotak\u0105, kad reguliuot\u0173 augim\u0105 bei metabolizm\u0105. IGF-1 LR3 yra modifikuota versija su strukt\u016briniais poky\u010diais, kurie suma\u017eina jos jungimosi baltym\u0173 afinitet\u0105 insulinin\u012f augimo faktor\u0105 jungti sugebantiems baltymams (IGFBP), kad b\u016bt\u0173 u\u017etikrintas ilgesnis aktyvumas nei nat\u016bralaus IGF-1.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">IGF-1 LR3 tre\u010dioji aminor\u016bg\u0161tis yra argininas, o ne glutamo r\u016bg\u0161tis, o peptidas jo N gale turi 13 papildom\u0173 aminor\u016bg\u0161\u010di\u0173. D\u0117l \u0161i\u0173 skirtum\u0173 jis yra IGF-1 receptoriaus agonistas, ta\u010diau turi tam tikr\u0173 prana\u0161um\u0173, \u012fskaitant tris kartus didesn\u012f veiksmingum\u0105 nei IGF-1. Jo pusin\u0117s eliminacijos periodas yra apie 20\u201330 valand\u0173 \u2013 daug ilgesnis nei nat\u016braliojo hormono 12\u201315 valand\u0173, \u2013 tod\u0117l jis u\u017etikrina ilgesn\u012f poveik\u012f nei nat\u016bralus IGF-1. Galiausiai, IGF-1 LR3 pasi\u017eymi geresniu metaboliniu stabilumu d\u0117l papildom\u0173 aminor\u016bg\u0161\u010di\u0173.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Kitaip tariant, IGF-1 LR3 modifikacijos padidina jo tyrim\u0173 potencial\u0105 raumen\u0173 augimui ir audini\u0173 atstatymui, tod\u0117l \u0161is peptidas yra naudingas estetiniams ir sportiniams tyrim\u0173 modeliams.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">IGF-1 LR3 palyginimas su IGF-1 DES<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Kita IGF-1 modifikacija yra insulino tipo augimo faktoriaus 1 delecija (1\u20133), paprastai sutrumpintai vadinama IGF-1 DES. Kaip ir IGF-1 LR3, tai yra sintetinis peptidas, sukurtas siekiant sustiprinti nat\u016braliojo IGF-1 naudingas savybes. IGF-1 DES atveju tai pasiekiama pa\u0161alinant pirmuosius tris N-galinius aminor\u016bg\u0161\u010di\u0173 liku\u010dius be joki\u0173 pried\u0173. Nustatyta, kad tokia modifikacija tam tikroje aplinkoje vyksta nat\u016braliai, o tai rodo, kad \u0161is hormonas tam tikrose situacijose organizme gali atlikti svarb\u0173 vaidmen\u012f.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Amino r\u016bg\u0161\u010di\u0173 pa\u0161alinimas IGF-1 DES suma\u017eina peptido giminingum\u0105 IGFBP ir padidina giminingum\u0105 IGF-1 receptoriui. \u0160iuo po\u017ei\u016briu jis skiriasi nuo IGF-1 LR3, kurio giminingumas IGF-1 receptoriui yra suma\u017e\u0117j\u0119s. B\u016btent \u0161is suma\u017e\u0117j\u0119s giminingumas lemia ilgesn\u012f pusin\u0117s eliminacijos period\u0105.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Tyr\u0117jai paprastai renkasi IGF-1 DES tyrimams, susijusiems su lygi\u0173j\u0173 raumen\u0173 l\u0105steli\u0173 migracija ir proliferacija, o ne griau\u010di\u0173 raumen\u0173 vystymuisi, kaip yra IGF-1 LR3 atveju. \u0160is peptidas taip pat gali atlikti vaidmen\u012f neurologiniuose tyrimuose, nebent tod\u0117l, kad jo nat\u016braliai aptinkama smegen\u0173 audinyje. Ta\u010diau d\u0117l trumpo pusin\u0117s eliminacijos periodo jis yra ma\u017eiau tinkamas tyrimams su \u017emon\u0117mis nei IGF-1 LR3.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">IGF-1 LR3 dozuojimo protokolai moksliniuose tyrimuose lyginant su biohakingu ir \u201eReddit\u201c prane\u0161imais<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">IGF-1 LR3 \u0161iuo metu n\u0117ra patvirtintas FDA, tod\u0117l jo naudojimas yra eksperimentinis ir apsiriboja tyrimais. Kaip ir vis\u0173 augimo peptid\u0173, tyrim\u0173 protokoluose tur\u0117t\u0173 b\u016bti atsi\u017evelgta \u012f dozavim\u0105 ir nepageidaujam\u0105 poveik\u012f metabolizmui.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Paskelbti tyrim\u0173 protokolai<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Paskelbti tyrimai nagrin\u0117ja, ar IGF-1 LR3 gali b\u016bti tinkamas modeliams, orientuotiems \u012f lies\u0105 raumen\u0173 mas\u0119, riebal\u0173 apykait\u0105 arba sen\u0117jimo biologij\u0105. Jis ypa\u010d populiarus tarp tyr\u0117j\u0173, kurie jau atlieka tyrimus su augimo hormono sekretagogaem.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Tyr\u0117jai, naudodami peptid\u0105, suk\u016br\u0117 protokolus, kuriais kiti gal\u0117t\u0173 vadovautis b\u016bsimuose kontroliuojamuose tyrimuose:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Tyrim\u0173 protokolai tur\u0117t\u0173 periodi\u0161kai steb\u0117ti cukraus kiek\u012f kraujyje d\u0117l hipoglikemijos pavojaus, nes peptidas gali paskatinti daugiau raumen\u0173 l\u0105steli\u0173 pasisavinti gliukoz\u0119 i\u0161 kraujotakos.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Apra\u0161yti \u012f tyrimus orientuoti protokolai nurodo 20\u201330 mikrogram\u0173 pradin\u0119 doz\u0119, kuri po vienos ar dviej\u0173 savai\u010di\u0173 padidinama iki 30\u201350 mikrogram\u0173. Nors kai kuriuose tyrimuose buvo naudojamos iki 100 mikrogram\u0173 doz\u0117s, juose nepavyko nustatyti, kad tai duot\u0173 naud\u0105, proporcing\u0105 padid\u0117jusiai rizikai.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">IGF-1 LR3 administravimas tyrim\u0173 kontekste da\u017enai b\u016bna poodinis d\u0117l praktini\u0173 prie\u017eas\u010di\u0173. Nors kai kurie tyr\u0117jai naudoja intramuskulines injekcijas, siekdami pasiekti didesn\u0119 lokalizuot\u0105 hipertrofij\u0105, n\u0117ra ai\u0161ki\u0173 \u012frodym\u0173, kad tai yra veiksminga.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Daugelis protokol\u0173 nurodo, kad tyr\u0117jai suplanuoja peptid\u0105 vartoti po treniruot\u0117s, nes fizinis kr\u016bvis suaktyvina IGF-1 receptori\u0173 rai\u0161k\u0105 ir padidina satelitini\u0173 l\u0105steli\u0173 jautrum\u0105.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Kad b\u016bt\u0173 i\u0161vengta receptori\u0173 desensibilizacijos, kai peptidas nebeturi jokio poveikio, tyrim\u0173 protokoluose da\u017enai taikomas cikli\u0161kas vartojimas. Tipinis eksperimentinis protokolas yra trys ar keturios savait\u0117s (arba net vos dvi savait\u0117s), po kuri\u0173 daroma ne ma\u017eesn\u0117 kaip keturi\u0173 savai\u010di\u0173 pertrauka.<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Biohakingas ir \u201eReddit\u201c prane\u0161imai<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Prane\u0161imai apie sav\u0119s eksperimentavim\u0105 su IGF-1 LR3 kaip greitu b\u016bdu numesti svorio, priaugti raumen\u0173 ar padaryti abu dalykus kelia susir\u016bpinim\u0105. Kadangi IGF-1 LR3 n\u0117ra patvirtintas FDA, su juo reik\u0117t\u0173 elgtis tik tyrim\u0173 tikslais kontroliuojamais atvejais, kai tiriamieji \u012ftraukia peptid\u0105 \u012f treniruo\u010di\u0173 plan\u0105 su tinkamu fiziniu kr\u016bviu ir tinkama mityba.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Prane\u0161ama, kad biohakeriavimas l\u0117m\u0117<\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9597049\/\" target=\"_blank\" rel=\"noopener\"> <span style=\"font-weight: 400;\">\u0160alutinis poveikis<\/span><\/a><span style=\"font-weight: 400;\"> \u012fskaitant:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Hipoglikemija<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Nerv\u0173 u\u017espaudimas<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">S\u0105nari\u0173 skausmas<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Vandens susilaikymas<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Standartini\u0173 protokol\u0173 laikymasis ir tyr\u0117jo u\u017etikrinimas, kad tiriamieji b\u016bt\u0173 stebimi, padeda suma\u017einti \u0161iuos prane\u0161tus \u0161alutinius poveikius kontroliuojamoje tyrim\u0173 aplinkoje.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Kas tur\u0117t\u0173 vengti IGF-1 LR3?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Pagrindin\u0117 su IGF-1 LR3 poveikiu susijusi rizika, ypa\u010d ilgalaik\u0117, apima atsparum\u0105 insulinui ir mitogenin\u012f poveik\u012f. \u0160is peptidas gali kelti pavoj\u0173 asmenims, sirgusiems v\u0117\u017eiu arba turintiems padid\u0117j\u012f PSA kiek\u012f, nes l\u0105steli\u0173 augim\u0105 jis skatina neatsi\u017evelgdamas \u012f j\u0173 tip\u0105.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Be to, profesional\u016bs sportininkai netur\u0117t\u0173 vartoti IGF-1 LR3, nes jis yra u\u017edraustas sporte.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Paruo\u0161imas ir laikymas<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">IGF-1 LR3 tiekiamas kaip sausi milteliai \u2013 jo liofilizuota forma. B\u016bdamas \u0161ios formos, jis turi b\u016bti laikomas \u0161aldiktyje -20 C temperat\u016broje arba kambario temperat\u016broje v\u0117sioje, tamsioje vietoje.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Prie\u0161 naudojant tyrime, IGF-1 LR3 yra atskied\u017eiamas bakteriostatiniu vandeniu. \u0160ios sumai\u0161ytos formos tereikia \u0161aldytuve (sumai\u0161ytas ir laikomas \u0161aldytuve, jis i\u0161lieka tinkamas iki 4 savai\u010di\u0173). Kad b\u016bt\u0173 i\u0161saugota peptido strukt\u016bra, svarbu vengti per stipraus flakono kratymo prie\u0161 naudojim\u0105.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">IGF-1 LR3 DUK<\/span><\/h2>\n<h3><span style=\"font-weight: 400;\">Kod\u0117l IGF-1 LR3 yra veiksmingesnis u\u017e nat\u016bral\u0173 IGF-1?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Daug ilgesnis IGF-1 LR3 pusin\u0117s eliminacijos periodas suteikia sintetiniam hormonui laiko padaryti didesn\u012f poveik\u012f tyrim\u0173 modeliuose. Trumpai veikiantis IGF-1 i\u0161silaiko nepakankamai ilgai, kad sukelt\u0173 toki\u0105 pastebim\u0105 baltym\u0173 sintez\u0119 ir palydovini\u0173 l\u0105steli\u0173 aktyvavim\u0105 gijimui bei maistini\u0173 med\u017eiag\u0173 perskirstymui riebal\u0173 apykaitos tyrimuose.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Kiek laiko IGF-1 LR3 gali b\u016bti tiriamas protokole?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">\u012e \u012fvairius tyrimus orientuoti protokolai da\u017enai tyrin\u0117ja IGF-1 LR3 iki keturi\u0173 savai\u010di\u0173, po kuri\u0173 daroma bent keturi\u0173 savai\u010di\u0173 pertrauka. \u0160is vartojimo ciklas palaiko receptori\u0173 jautrum\u0105 ir rei\u0161kia, kad peptidas ir toliau veikia. Tyr\u0117jai gali nustatyti, kad tiriamieji peptid\u0105 tur\u0117t\u0173 gauti tik treniruo\u010di\u0173 dienomis, nors kai kurie gali nustatyti protokol\u0105, apimant\u012f doz\u0119 prie\u0161 mieg\u0105 poilsio dienomis.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Ar IGF-1 LR3 veikia gerai su kitais peptidais?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Tyr\u0117jams \u012fprasta \u012ftraukti IGF-1 LR3 \u012f tyrimus su kitais peptidais, ypa\u010d turin\u010diais pana\u0161i\u0173 savybi\u0173, tokiais kaip:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">BPC-157 \u2014 I\u0161tirtas u\u017edegimo ir audini\u0173 regeneracijos modeliuose, ypa\u010d po treniruot\u0117s ar mink\u0161t\u0173j\u0173 audini\u0173 traum\u0173.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">TB-500 \u2013 dar vienas tiriamas gijimo peptidas, skirtas raumen\u0173 ir sausgysli\u0173 traum\u0173 atsistatymui.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">CJC-1295 su ipamorelinu \u2013 du augimo hormono sekretagogai; \u0161ie peptidai yra tiriami kartu su IGF-1 LR3 raumen\u0173 vystymuisi, svorio metimui arba sen\u0117jimo biologijai, imituojant nat\u016brali\u0105 hormon\u0173 gamyb\u0105.<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Kada tyr\u0117jai prane\u0161a apie IGF-1 LR3 protokol\u0173 rezultatus?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Tyr\u0117jai prane\u0161\u0117 apie pastebimus raumen\u0173 augimo poky\u010dius ma\u017edaug po dviej\u0173 ar trij\u0173 savai\u010di\u0173 nuo pirmojo IGF-1 LR3 ciklo prad\u017eios.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><span style=\"font-weight: 400;\">Nuorodos<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">1. Insulino tipo augimo faktoriaus-I analogo matavimas kraujo plazmoje naudojant nauj\u0105 imunofermentin\u0117s analiz\u0117s metod\u0105 \u2013 <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9582496\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/9582496\/<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">2. Ilgalaik\u0117 R3 insulino tipo augimo faktoriaus-I (IGF-I) infuzija stimuliuoja organ\u0173 augim\u0105, bet suma\u017eina IGF-I, IGF-II ir IGF veikian\u010di\u0173 baltym\u0173 koncentracijas plazmoje j\u016br\u0173 kiaulyt\u0117ms <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/7561636\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/7561636\/<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">3. Fosfatidilinozitolio 3-kinaz\u0117 ir p70 s6 kinaz\u0117 dalyvauja reguliuojant baltym\u0173 apykait\u0105 skeleto raumenyse, kuri\u0105 veikia insulinas ir \u012f insulin\u0105 pana\u0161us augimo faktorius I <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/8828461\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/8828461\/<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">4. IGF-1 sukeltos skeleto raumen\u0173 skaidul\u0173 (miotub\u0173) hipertrofijos tarpininkavimas per PI(3)K\/Akt\/mTOR ir PI(3)K\/Akt\/GSK3 signalinius keli\u0173 \u2013 <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/11715022\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/11715022\/<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">5. Insulino tipo augimo faktorius-I pailgina skeleto raumen\u0173 palydovini\u0173 l\u0105steli\u0173 in vitro replikacin\u012f gyvavimo cikl\u0105, skatindamas G1\/S l\u0105stel\u0117s ciklo eig\u0105 per fosfatidilinozitolio 3'-kinoz\u0117s \/ Akt signalinio kelio aktyvavim\u0105 \u2013 <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10962000\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/10962000\/<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">6. Suma\u017e\u0117j\u0119s gliukoz\u0117s stimuliuojamas insulino i\u0161siskyrimas po 1 savait\u0117s IGF-1 infuzijos v\u0117lyvojo vaikingumo avies vaisiui yra susij\u0119s su vidiniu saleli\u0173 defektu \u2013 <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33938236\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33938236\/<\/a><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p><span style=\"font-weight: 400;\">Ikiklinikiniuose ir laboratoriniuose tyrimuose tyr\u0117jai tyr\u0117<strong> IGF-1 LR3<\/strong> kaip peptidas, galintis paskatinti raumen\u0173 augim\u0105, pagreitinti atsistatym\u0105 po treniruo\u010di\u0173, paveikti riebal\u0173 apykait\u0105 ir palaikyti odos atsinaujinim\u0105. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u0160ios tyrim\u0173 sritis l\u0117m\u0117, kad peptidas tapo populiarus sportini\u0173 rezultat\u0173, svorio metimo ir sen\u0117jimo stabdymo diskusijose.<\/span><\/p>","protected":false},"featured_media":15057,"template":"","meta":{"_acf_changed":false,"ub_ctt_via":""},"product_brand":[],"product_cat":[61,45,47,44],"product_tag":[],"class_list":["post-15052","product","type-product","status-publish","has-post-thumbnail","product_cat-bestsellers","product_cat-peptides-for-fat-metabolism-research","product_cat-igf-1-growth-hormone-research","product_cat-peptides-for-muscle-growth-research","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Buy IGF-1 LR3 (99% Purity) - CellPeptides<\/title>\n<meta name=\"description\" content=\"Buy IGF-1 LR3 researched for growth factor and muscle hypertrophy. 99% purity, HPLC tested. Click here to get it today.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cellpeptides.com\/lt\/product\/buy-igf-1-lr3\/\" \/>\n<meta property=\"og:locale\" content=\"lt_LT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Buy IGF-1 LR3 (99% Purity) - CellPeptides\" \/>\n<meta property=\"og:description\" content=\"Buy IGF-1 LR3 researched for growth factor and muscle hypertrophy. 99% purity, HPLC tested. Click here to get it today.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cellpeptides.com\/lt\/product\/buy-igf-1-lr3\/\" \/>\n<meta property=\"og:site_name\" content=\"CellPeptides\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-18T10:25:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"8 minut\u0117s\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/\",\"url\":\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/\",\"name\":\"Buy IGF-1 LR3 (99% Purity) - CellPeptides\",\"isPartOf\":{\"@id\":\"https:\/\/cellpeptides.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png\",\"datePublished\":\"2026-08-12T08:43:21+00:00\",\"dateModified\":\"2026-08-18T10:25:44+00:00\",\"description\":\"Buy IGF-1 LR3 researched for growth factor and muscle hypertrophy. 99% purity, HPLC tested. Click here to get it today.\",\"breadcrumb\":{\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#breadcrumb\"},\"inLanguage\":\"lt-LT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#primaryimage\",\"url\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png\",\"contentUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png\",\"width\":1200,\"height\":1200,\"caption\":\"IGF-1 LR3 1mg_mockup\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cellpeptides.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop\",\"item\":\"https:\/\/cellpeptides.com\/shop\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IGF-1 LR3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cellpeptides.com\/#website\",\"url\":\"https:\/\/cellpeptides.com\/\",\"name\":\"CellPeptides\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/cellpeptides.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cellpeptides.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"lt-LT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cellpeptides.com\/#organization\",\"name\":\"CellPeptides\",\"url\":\"https:\/\/cellpeptides.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png\",\"contentUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png\",\"width\":697,\"height\":152,\"caption\":\"CellPeptides\"},\"image\":{\"@id\":\"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pirkti IGF-1 LR3 (grynumas 99%) \u2013 \u201eCellPeptides\u201c","description":"\u012esigykite IGF-1 LR3, kurio veiksmingumas augimo faktoriaus ir raumen\u0173 hipertrofijos srityje yra moksli\u0161kai pagr\u012fstas. 99% grynumas, patikrintas HPLC metodu. Spauskite \u010dia, kad j\u012f \u012fsigytum\u0117te jau \u0161iandien.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cellpeptides.com\/lt\/product\/buy-igf-1-lr3\/","og_locale":"lt_LT","og_type":"article","og_title":"Buy IGF-1 LR3 (99% Purity) - CellPeptides","og_description":"Buy IGF-1 LR3 researched for growth factor and muscle hypertrophy. 99% purity, HPLC tested. Click here to get it today.","og_url":"https:\/\/cellpeptides.com\/lt\/product\/buy-igf-1-lr3\/","og_site_name":"CellPeptides","article_modified_time":"2026-08-18T10:25:44+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"8 minut\u0117s"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/","url":"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/","name":"Pirkti IGF-1 LR3 (grynumas 99%) \u2013 \u201eCellPeptides\u201c","isPartOf":{"@id":"https:\/\/cellpeptides.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#primaryimage"},"image":{"@id":"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#primaryimage"},"thumbnailUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png","datePublished":"2026-08-12T08:43:21+00:00","dateModified":"2026-08-18T10:25:44+00:00","description":"\u012esigykite IGF-1 LR3, kurio veiksmingumas augimo faktoriaus ir raumen\u0173 hipertrofijos srityje yra moksli\u0161kai pagr\u012fstas. 99% grynumas, patikrintas HPLC metodu. Spauskite \u010dia, kad j\u012f \u012fsigytum\u0117te jau \u0161iandien.","breadcrumb":{"@id":"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#breadcrumb"},"inLanguage":"lt-LT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/"]}]},{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#primaryimage","url":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png","contentUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/IGF-1-LR3-1mg_mockup_no_expiry_highres.png","width":1200,"height":1200,"caption":"IGF-1 LR3 1mg_mockup"},{"@type":"BreadcrumbList","@id":"https:\/\/cellpeptides.com\/product\/buy-igf-1-lr3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cellpeptides.com\/"},{"@type":"ListItem","position":2,"name":"Shop","item":"https:\/\/cellpeptides.com\/shop\/"},{"@type":"ListItem","position":3,"name":"IGF-1 LR3"}]},{"@type":"WebSite","@id":"https:\/\/cellpeptides.com\/#website","url":"https:\/\/cellpeptides.com\/","name":"L\u0105steli\u0173 peptidai","description":"","publisher":{"@id":"https:\/\/cellpeptides.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cellpeptides.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"lt-LT"},{"@type":"Organization","@id":"https:\/\/cellpeptides.com\/#organization","name":"L\u0105steli\u0173 peptidai","url":"https:\/\/cellpeptides.com\/","logo":{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/","url":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png","contentUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png","width":697,"height":152,"caption":"CellPeptides"},"image":{"@id":"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cellpeptides.com\/lt\/wp-json\/wp\/v2\/product\/15052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cellpeptides.com\/lt\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/cellpeptides.com\/lt\/wp-json\/wp\/v2\/types\/product"}],"version-history":[{"count":0,"href":"https:\/\/cellpeptides.com\/lt\/wp-json\/wp\/v2\/product\/15052\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cellpeptides.com\/lt\/wp-json\/wp\/v2\/media\/15057"}],"wp:attachment":[{"href":"https:\/\/cellpeptides.com\/lt\/wp-json\/wp\/v2\/media?parent=15052"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/cellpeptides.com\/lt\/wp-json\/wp\/v2\/product_brand?post=15052"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/cellpeptides.com\/lt\/wp-json\/wp\/v2\/product_cat?post=15052"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/cellpeptides.com\/lt\/wp-json\/wp\/v2\/product_tag?post=15052"}],"curies":[{"name":"gerai \u017eaista","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}